Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)

Fig. 1

a Natural logarithm of urine albumin-to-creatinine ratio (log-UACR), b non-logarithmic UACR values, and c estimated glomerular filtration (eGFR) induced by add-on dapagliflozin treatment during the 24-week study period. The change from baseline to week 24 was analyzed using a one-sided paired t-test. *P < 0.05, ***P < 0.005, ****P < 0.001

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840